Sanofi-Aventis S.A. ADR (SNY)
$48.89
0.47 (0.96%)
SNY Stock Quote Delayed 30 Minutes
SNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024
SNY stock results show that Sanofi beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
61.14B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
577,366
Day's Range
$48.65 - $49.07
52-Week Range
$42.63 - $57.82
Dividend & Yield
$1.90 (3.89%)
SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!
Why Is Provention Bio (PRVB) Stock Up 263% Today?
Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.
Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts
One pharmaceutical producer is implementing job cuts. Here's what investors need to know about the Sanofi layoffs.
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker.
GSK, PFE, SNY Stocks Fall on Zantac Litigation
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!
KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket
Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.
